Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03062111 · ClinicalTrials.gov registry record · NA
Laser Enucleation of Prostate (LEP) Versus Transurethral Resection of Prostate (TURP)
A NA study, sponsored by Boston University.
- Terminated
- Registry status
- NA
- Development phase
- 3
- Enrollment target
NCT03062111: Clinical Trial NA study, sponsored by Boston University.
NCT03062111 is a NA study that was terminated before completion, run by Boston University. The registered enrollment target is 3 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03062111, a NA study, was terminated before completion, sponsored by Boston University.
- TERMINATED
- Registry status
- NA
- Development phase
- 3 participants
- Enrollment target
Study Summary
Benign prostatic hyperplasia (BPH) refers to the proliferation of smooth muscle and epithelial cells of the prostate gland. The enlarged gland has the potential to result in lower urinary tract symptoms (LUTS) secondary to either bladder outlet obstruction or increased muscle tone and resistance, or both. For decades transurethral resection of the prostate (TURP) has been the gold standard for treatment of symptomatic BPH that is refractory to nonoperative management. This is a surgical intervention aimed to reduce the size of the prostate gland. However, over the past fifteen years, many alternative therapies have been introduced including laser enucleation of the prostate (LEP). LEP has numerous advantages including decreased blood loss and length of hospital stay as well as increased effectiveness and safety for large prostate gland sizes (\>80g).
Primary Outcome
Velocity (in cc/sec) of the urine flow
Interventions
- PROCEDURE ProTouch Laser Enucleation of Prostate (LEP)
- PROCEDURE Transurethral Resection of Prostate (TURP)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2017-10-23 |
| Est. Completion | 2021-01-15 |
| Phase | NA |
Why NCT03062111 stopped before completion
NCT03062111 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 3 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 2 interventions - of which ProTouch Laser Enucleation of Prostate (LEP) is the first listed.
NCT03062111 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03062111 about?
NCT03062111 is a clinical study titled "Laser Enucleation of Prostate (LEP) Versus Transurethral Resection of Prostate (TURP)". Benign prostatic hyperplasia (BPH) refers to the proliferation of smooth muscle and epithelial cells of the prostate gland. The enlarged gland has the potential to result in lower urinary tract symptoms (LUTS) secondary to either bladder outlet obstruction or increased muscle tone and resistance, or...
What is the current status of trial NCT03062111?
This trial is currently terminated. It is a NA study. The enrollment target is 3 participants. The study started on 2017-10-23. Estimated completion is 2021-01-15.
What interventions are being tested in trial NCT03062111?
The interventions under investigation include: ProTouch Laser Enucleation of Prostate (LEP) (PROCEDURE), Transurethral Resection of Prostate (TURP) (PROCEDURE).
Who is sponsoring clinical trial NCT03062111?
This trial is sponsored by Boston University, which has 185 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03062111's enrollment target sits among peer trials
3 1996th of 2000 higher than 4 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI